fimaVACC / PCI Biotech - LARVOL DELTA

HA2-FimA DNA Vaccine Treats Experimental Periodontitis. (PubMed, Oral Health Prev Dent) - "HA2-FimA DNA vaccine can increase the levels of SIgA and CAMP in the saliva of experimental periodontitis model rats and reduce alveolar bone loss."

Journal • Dental Disorders • Osteoporosis • Periodontitis

PCI Biotech interim Q4 2022 results (GlobeNewswire) - "FimaVacc – intratumoural immunotherapy - PCI Biotech is exploring approaches aimed at identifying novel immunotherapy treatment combination, and first patent application for an undisclosed treatment approach is underway for filing in Q1 2023."

Patent • Oncology